Print view
 

COVID-19 severity affected by proportion of antibodies targeting crucial viral protein

Stanford University School of Medicine

COVID-19 antibodies preferentially target a different part of the virus in mild cases of COVID-19 than they do in severe cases, and wane significantly within several months of infection, according to a new study by researchers at Stanford Medicine

The findings identify new links between the course of the disease and a patient’s immune response. They also raise concerns about whether people can be re-infected, whether antibody tests to detect prior infection may underestimate the breadth of the pandemic and whether vaccinations may need to be repeated at regular intervals to maintain a protective immune response. 

 “This is one of the most comprehensive studies to date of the antibody immune response to SARS-CoV-2 in people across the entire spectrum of disease severity, from asymptomatic to fatal,” said Scott Boyd, MD, PhD, associate professor of pathology. “We assessed multiple time points and sample types, and also analyzed levels of viral RNA in patient nasopharyngeal swabs and blood samples. It’s one of the first big-picture looks at this illness.”

Read the whole article here.

Autor: Krista Conger   Quelle: Stanford University School of Medicine, Stanford Health Care (formerly Stanford Hospital & Clinics), 28.12.2020
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
 

European Health Forum GasteinCenter of ExcellenceEuropean Public Health Association (EUPHA)Hilfswerk AustriaAMREF - African Medical and Research FoundationnewTreeCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioHelix - Forschung & Beratung Wien